Patrick McGann

Director, Pediatric and Adult Sickle Cell and Hemoglobinopathy Program; Rhode Island Hospital and Its Hasbro Children’s Hospital · Rhode Island Hospital/Brown University Health

Credentials: · · · · · · · ·

History

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
New England Journal of Medicine · 2019 · 266 citations
Hydroxyurea therapy for sickle cell anemia
Review · Expert Opinion on Drug Safety · 2015 · First of 2 authors · 225 citations
When Actions Speak Louder Than Words - Racism and Sickle Cell Disease
New England Journal of Medicine · 2020 · 177 citations

Mobile Phone-Based Screening for Anemia in Young Children in Western Kenya
National Institute of Child Health and Human Development · R33
Contact PI · $585.8K · Rhode Island Hospital
2023–2028
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
National Heart, Lung, and Blood Institute · U01
Contact PI · $1.7M · Rhode Island Hospital
2021–2027
Mobile Phone-Based Screening for Anemia in Young Children in Western Kenya
National Institute of Child Health and Human Development · R21
Contact PI · $383.2K · Rhode Island Hospital
2023–2025
Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell Anemia
National Institute of Child Health and Human Development · R21
Contact PI · $370K · Rhode Island Hospital
2022–2025

Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
Principal investigator · Recruiting · Phase 3
Brown University
2023–2027